Acute cholecystitis during COVID-19 pandemic: A multisocietary position statement
- Authors: Campanile F.C.; Podda M.; Arezzo A.; Botteri E.; Sartori A.; Guerrieri M.; Cassinotti E.; Muttillo I.; Pisano M.; Brachet Contul R.; D'Ambrosio G.; Cuccurullo D.; Bergamini C.; Allaix M.E.; Caracino V.; Petz W.L.; Milone M.; Silecchia G.; Anania G.; Agrusa A.; Di Saverio S.; Casarano S.; Cicala C.; Narilli P.; Federici S.; Carlini M.; Paganini A.; Bianchi P.P.; Salaj A.; Mazzari A.; Meniconi R.L.; Puzziello A.; Terrosu G.; De Simone B.; Coccolini F.; Catena F.; Agresta F.
- Publication year: 2020
- Type: Articolo in rivista
- OA Link: http://hdl.handle.net/10447/431836
Abstract
Following the spread of the infection from the new SARS-CoV2 coronavirus in March 2020, several surgical societies have released their recommendations to manage the implications of the COVID-19 pandemic for the daily clinical practice. The recommendations on emergency surgery have fueled a debate among surgeons on an international level. We maintain that laparoscopic cholecystectomy remains the treatment of choice for acute cholecystitis, even in the COVID-19 era. Moreover, since laparoscopic cholecystectomy is not more likely to spread the COVID-19 infection than open cholecystectomy, it must be organized in such a way as to be carried out safely even in the present situation, to guarantee the patient with the best outcomes that minimally invasive surgery has shown to have.